Related Experiment Video
Updated: Oct 16, 2025
Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Dermatofibrosarcoma Protuberans Presenting in a Patient With Neurofibromatosis Type 1: Potential Implications on
Bianca N Eubanks1, Dawood A Tafti2, Sabrina House3
1Medicine, Uniformed Services University of the Health Sciences, Bethesda, USA.
Dermatofibrosarcoma protuberans (DFSP), a rare sarcoma, was diagnosed alongside Neurofibromatosis type 1 (NF1) in a patient. This case suggests imatinib mesylate may offer a unique treatment for both conditions.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing cutaneous soft tissue sarcoma.
- Neurofibromatosis type 1 (NF1) is a genetic disorder affecting nerve tissue growth.
Observation:
- A 47-year-old male presented with a two-year history of a right lower back lesion diagnosed as DFSP.
- The patient also exhibited café-au-lait spots, freckling, and neurofibromas, leading to an NF1 diagnosis.
Findings:
- Wide local excision achieved complete DFSP tumor removal with no recurrence over six years.
- This case represents the second report of co-occurring DFSP and NF1 in a single patient.
Implications:
- The co-occurrence suggests imatinib mesylate, a treatment for both conditions, may be a viable therapeutic option.
- Further research into imatinib's efficacy for combined DFSP and NF1 is warranted.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
